Semi Anthelme Nene Bi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Semi Anthelme Nene Bi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Ahoua Yapi
Laboratory of Biology and Health, Felix Houphouët-Boigny University, Abidjan, Côte d’Ivoire
1 shared publicationAntoine Tako
Laboratory of Biology and Health, Felix Houphouët-Boigny University, Abidjan, Côte d’Ivoire
1 shared publicationAugustin N&Apos;Da Kouassi Kangah
1 shared publicationFidèle Ziéhi Kpahie
Laboratoire de Biodiversité et d'Ecologie Tropicale, Université Jean Lorougnon Guédé, BP 150 Daloa, Côte
1 shared publicationFlavien Traore
Laboratory of Biology and Health, Training and Research Unit Biosciences, Felix Houphouet-Boigny University (Côte d’Ivoire), 22 BP 582 Abidjan 22
1 shared publication- Gbê Badie
Laboratory of Biology and Health, Felix Houphouët-Boigny University, Abidjan, Côte d’Ivoire
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Elsevier in SSRN Electronic Journal
Age-Related Oxidative Stress in the Brain of the African Grasscutter (Thryonomys swinderianus TEMMINCK, 1827 (Thryonomidae)): A Biomarker Study
Abstrract,Brain aging is characterized by progressive oxidative damage resulting from an imbalance between reactive oxygen species production and antioxidant defense systems. Although oxidative stress has been extensively investigated in conventional laboratory rodents, comparable data from African mammalian species remain scarce. The aim of the present study was to investigate age-related changes in four major oxidative stress biomarkers in the brain of the African Grasscutter (Thryonomys swinderianus), an indigenous African rodent with increasing value for comparative neuroscience and biomedical research. Brain samples were collected from animals ranging from 6 days to 5 years of age. Oxidative stress biomarkers were quantified using standard spectrophotometric methods, and age-dependent relationships were assessed by regression and correlation analyses. Brain NO and MDA levels increased progressively with advancing age, showing strong positive correlations with age (r = 0.96 and r = 0.97, respectively), indicating enhanced nitrosative stress and lipid peroxidation. In contrast, GSH concentrations gradually declined, although the correlation did not reach statistical significance (r = -0.62, P > 0.05). CAT activity exhibited a biphasic profile, increasing during early development before declining markedly with aging (r = -0.76). Overall, the biochemical profile demonstrates a progressive shift toward a pro-oxidant state characterized by increased oxidative damage and reduced antioxidant capacity.
- 20 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAge-Related Oxidative Stress in the Brain of the African Grasscutter (Thryonomys swinderianus TEMMINCK, 1827 (Thryonomidae)): A Biomarker Study
Abstrract,Brain aging is characterized by progressive oxidative damage resulting from an imbalance between reactive oxygen species production and antioxidant defense systems. Although oxidative stress has been extensively investigated in conventional laboratory rodents, comparable data from African mammalian species remain scarce. The aim of the present study was to investigate age-related changes in four major oxidative stress biomarkers in the brain of the African Grasscutter (Thryonomys swinderianus), an indigenous African rodent with increasing value for comparative neuroscience and biomedical research. Brain samples were collected from animals ranging from 6 days to 5 years of age. Oxidative stress biomarkers were quantified using standard spectrophotometric methods, and age-dependent relationships were assessed by regression and correlation analyses. Brain NO and MDA levels increased progressively with advancing age, showing strong positive correlations with age (r = 0.96 and r = 0.97, respectively), indicating enhanced nitrosative stress and lipid peroxidation. In contrast, GSH concentrations gradually declined, although the correlation did not reach statistical significance (r = -0.62, P > 0.05). CAT activity exhibited a biphasic profile, increasing during early development before declining markedly with aging (r = -0.76). Overall, the biochemical profile demonstrates a progressive shift toward a pro-oxidant state characterized by increased oxidative damage and reduced antioxidant capacity.
- 11 May 2026
- Published by Science Publishing Group in Central African Journal of Public Health
- Vol. 12 (3) , 148-153
Acute Effects of the Johnson & Johnson COVID-19 Vaccine on Cognitive Functions: A Cross-sectional Study in Côte d'Ivoire
Acute neurocognitive effects of COVID-19 vaccines remain poorly documented, particularly in African populations. The systemic inflammatory response following vaccination could transiently modulate brain function. This study aimed to conduct an exploratory cross-sectional assessment of the acute effects of the Johnson & Johnson vaccine on selective attention and verbal memory in participants from Côte d'Ivoire. We compared the cognitive performance of 28 participants tested 30 minutes after receiving the Johnson & Johnson vaccine with 28 non-vaccinated controls. Participants were stratified by educational level (primary, secondary, university). Cognitive performance was assessed using the Stroop test and the Rey Auditory Verbal Learning Test (RAVLT). Independent samples t‑tests were applied with significance set at p ≤ 0.05. A statistically significant improvement in Stroop interference performance (selective attention) was observed in the vaccinated secondary-level group compared to controls (p = 0.005). In the primary-level group, vaccinated participants showed significantly lower scores on the RAVLT deferred recognition task (p = 0.01). No other significant differences were found for RAVLT performance or for other Stroop conditions and educational levels. This exploratory study did not find evidence of widespread acute cognitive deficits following vaccination with the Johnson & Johnson vaccine. However, the specific effects observed, a potential enhancement of attention in secondary-level group and a potential disruption of memory recognition in the primary-level group, highlight the need for larger, longitudinal studies to confirm these findings and explore the underlying neuro-immune mechanisms.
- 11 May 2026
- Published by Science Publishing Group in Central African Journal of Public Health
- Vol. 12 (3) , 148-153
Acute Effects of the Johnson & Johnson COVID-19 Vaccine on Cognitive Functions: A Cross-sectional Study in Côte d'Ivoire
Acute neurocognitive effects of COVID-19 vaccines remain poorly documented, particularly in African populations. The systemic inflammatory response following vaccination could transiently modulate brain function. This study aimed to conduct an exploratory cross-sectional assessment of the acute effects of the Johnson & Johnson vaccine on selective attention and verbal memory in participants from Côte d'Ivoire. We compared the cognitive performance of 28 participants tested 30 minutes after receiving the Johnson & Johnson vaccine with 28 non-vaccinated controls. Participants were stratified by educational level (primary, secondary, university). Cognitive performance was assessed using the Stroop test and the Rey Auditory Verbal Learning Test (RAVLT). Independent samples t‑tests were applied with significance set at p ≤ 0.05. A statistically significant improvement in Stroop interference performance (selective attention) was observed in the vaccinated secondary-level group compared to controls (p = 0.005). In the primary-level group, vaccinated participants showed significantly lower scores on the RAVLT deferred recognition task (p = 0.01). No other significant differences were found for RAVLT performance or for other Stroop conditions and educational levels. This exploratory study did not find evidence of widespread acute cognitive deficits following vaccination with the Johnson & Johnson vaccine. However, the specific effects observed, a potential enhancement of attention in secondary-level group and a potential disruption of memory recognition in the primary-level group, highlight the need for larger, longitudinal studies to confirm these findings and explore the underlying neuro-immune mechanisms.
- Open Access
- 6 March 2023
- Published by African Journals Online (AJOL) in International Journal of Biological and Chemical Sciences
- Vol. 16 (6) , 2494-2505
Evaluation de l’activité cicatrisante de l’extrait aqueux de l’écorce de tronc de Terminalia superba (Combretaceae)
Terminalia superba (Combretaceae) est une plante couramment utilisée en médecine traditionnelle africaine pour traiter plusieurs maladies entre autres les soins des plaies. Le but de notre étude était d’évaluer les propriétés cicatrisantes de l’écorce de tronc de Terminalia superba sur des plaies d’incision de second degré chez le rat Wistar. Cette étude s’est réalisée sur 30 rats repartis en 5 lots de 6 rats dont un lot témoin non traité et les 4 autres recevant des applications quotidiennes de substances tests. Les résultats ont montré que l’extrait aqueux d’écorce de tronc de Terminalia superba a entraîné une contraction importante des plaies qui atteint au quatorzième jour 96,29%, 92,22% et 90,73% pour les lots traités avec la plante respectivement aux concentrations 800 ; 400 et 200 mg/ml contre 53,32% et 37,91% pour les lots traités avec la Bétadine et le témoin. Cet effet est dû aux substances bioactives présentent au sein de la plante. Ces résultats suggèrent donc que cet extrait a une activité cicatrisante. In order to contribute to the enhancement of the use of plants used in traditional medicine for improving the health of populations including wound care, the aim of this study was to evaluate the healing properties of Terminalia superba bark of the runk on incision wounds in second degree in Wistar rats. This study was carried out on 30 rats divided into 5 batches of 6 rats, one of which was an untreated control and the other 4 received daily applications of test substances. The results showed a significant contraction reaches on the fourteenth day 96.29%, 92.22% and 90.73% for the batches treated with the plant respectively at concentrations 800, 400 and 200 mg/ml against 53.32% and 37.91% for the batches treated with Betadine and the control. This effect of the extract is due to the bioactive substances present in the plant. These results therefore suggest that this extract has a healing activity.
- 6 March 2023
- Published by African Journals Online (AJOL) in International Journal of Biological and Chemical Sciences
- Vol. 16 (6) , 2494-2505
Open AccessEvaluation de l’activité cicatrisante de l’extrait aqueux de l’écorce de tronc de Terminalia superba (Combretaceae)
Terminalia superba (Combretaceae) est une plante couramment utilisée en médecine traditionnelle africaine pour traiter plusieurs maladies entre autres les soins des plaies. Le but de notre étude était d’évaluer les propriétés cicatrisantes de l’écorce de tronc de Terminalia superba sur des plaies d’incision de second degré chez le rat Wistar. Cette étude s’est réalisée sur 30 rats repartis en 5 lots de 6 rats dont un lot témoin non traité et les 4 autres recevant des applications quotidiennes de substances tests. Les résultats ont montré que l’extrait aqueux d’écorce de tronc de Terminalia superba a entraîné une contraction importante des plaies qui atteint au quatorzième jour 96,29%, 92,22% et 90,73% pour les lots traités avec la plante respectivement aux concentrations 800 ; 400 et 200 mg/ml contre 53,32% et 37,91% pour les lots traités avec la Bétadine et le témoin. Cet effet est dû aux substances bioactives présentent au sein de la plante. Ces résultats suggèrent donc que cet extrait a une activité cicatrisante. In order to contribute to the enhancement of the use of plants used in traditional medicine for improving the health of populations including wound care, the aim of this study was to evaluate the healing properties of Terminalia superba bark of the runk on incision wounds in second degree in Wistar rats. This study was carried out on 30 rats divided into 5 batches of 6 rats, one of which was an untreated control and the other 4 received daily applications of test substances. The results showed a significant contraction reaches on the fourteenth day 96.29%, 92.22% and 90.73% for the batches treated with the plant respectively at concentrations 800, 400 and 200 mg/ml against 53.32% and 37.91% for the batches treated with Betadine and the control. This effect of the extract is due to the bioactive substances present in the plant. These results therefore suggest that this extract has a healing activity.
- Open Access
- 15 November 2021
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 11 (6) , 94-100
Acute and subacute toxicity assessment of an aqueous extract of Crotalaria retusa (Fabaceae) in Swiss mice and Wistar rats
The present study is a contribution to the enhancement of Ivorian traditional medicine, by carrying out bio-tolerance tests of an aqueous extract of the aerial parts of Crotalaria retusa (EACr) in mice and rats according to the guidelines of the Organization for Economic Co-operation and Development (OECD) 423 and 407, respectively. The doses of 2000 and 5000 mg/kg of body weight (BW) of the extract were used for acute toxicity. For subacute toxicity which lasted 28 days, doses of 500, 1000, and 2000 mg/kg BW have been used. The administration of the single doses of 2000 and 5000 mg/kg BW of EACr did not provoke death in female mice in the acute toxicity setting. For subacute toxicity in rats (male and female), the administration of repetitive doses of 500, 1000, and 2000 mg/kg BW of EACr over a period of 28 days did not cause death in these animals. In females, these doses caused weight loss and a decrease in platelets. The extract reduced the activity of AST in both sexes of rats. The findings also showed that this extract would possess a nephroprotective property in male and female rats. Keywords: Crotalaria retusa, Acute and subacute toxicities, Wistar rat, Swiss mice
- 15 November 2021
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 11 (6) , 94-100
Open AccessAcute and subacute toxicity assessment of an aqueous extract of Crotalaria retusa (Fabaceae) in Swiss mice and Wistar rats
The present study is a contribution to the enhancement of Ivorian traditional medicine, by carrying out bio-tolerance tests of an aqueous extract of the aerial parts of Crotalaria retusa (EACr) in mice and rats according to the guidelines of the Organization for Economic Co-operation and Development (OECD) 423 and 407, respectively. The doses of 2000 and 5000 mg/kg of body weight (BW) of the extract were used for acute toxicity. For subacute toxicity which lasted 28 days, doses of 500, 1000, and 2000 mg/kg BW have been used. The administration of the single doses of 2000 and 5000 mg/kg BW of EACr did not provoke death in female mice in the acute toxicity setting. For subacute toxicity in rats (male and female), the administration of repetitive doses of 500, 1000, and 2000 mg/kg BW of EACr over a period of 28 days did not cause death in these animals. In females, these doses caused weight loss and a decrease in platelets. The extract reduced the activity of AST in both sexes of rats. The findings also showed that this extract would possess a nephroprotective property in male and female rats. Keywords: Crotalaria retusa, Acute and subacute toxicities, Wistar rat, Swiss mice